Literature DB >> 27494176

A green tea-containing starch confection increases plasma catechins without protecting against postprandial impairments in vascular function in normoglycemic adults.

Teryn N Sapper1, Eunice Mah, Jennifer Ahn-Jarvis, Joshua D McDonald, Chureeporn Chitchumroonchokchai, Elizabeth J Reverri, Yael Vodovotz, Richard S Bruno.   

Abstract

Postprandial hyperglycemia (PPH) increases cardiovascular disease risk regardless of glucose intolerance by transiently impairing vascular endothelial function (VEF) by limiting nitric oxide bioavailability in an oxidative stress-dependent manner. Preclinical studies show that green tea catechins attenuate PPH by inhibiting starch digestion. We hypothesized that a starch-based confection containing catechin-rich green tea extract (GTE) would limit PPH-mediated impairments in VEF in normoglycemic adults. We formulated a unique GTE confection and then conducted a double-blind, randomized, controlled, crossover study in healthy men (n = 15; 25.3 ± 1.0 years; 22.4 ± 1.8 kg m(-2)) in which they ingested starch confections (50 g carbohydrate) formulated with or without GTE (1 g) prior to evaluating sensory characteristics of confections and plasma glucose, biomarkers of lipid peroxidation and nitric oxide homeostasis, and brachial artery flow-mediated dilation (FMD) at 30 min intervals for 3 h. Sensory evaluation of confections indicated acceptable consumer appeal and an inability to distinguish between confections regardless of GTE. Plasma catechins concentrations increased following ingestion of the GTE confection. However, plasma glucose peaked at 60 min (P < 0.05) following confection ingestion and was unaffected throughout the postprandial period by the GTE confection (P > 0.05). FMD was significantly decreased only at 60 min regardless of confections containing GTE. Also at 60 min, both confections similarly increased plasma malondialdehyde while decreasing arginine and increasing asymmetric dimethylarginine/arginine. The successfully formulated GTE-containing confection effectively delivered catechins, but without mitigating PPH-mediated impairments in VEF in association with oxidative stress that likely limits nitric oxide bioavailability.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27494176      PMCID: PMC6378873          DOI: 10.1039/c6fo00639f

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  44 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values.

Authors:  Alexander Kratz; Maryjane Ferraro; Patrick M Sluss; Kent B Lewandrowski
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

2.  High-throughput analysis of catechins and theaflavins by high performance liquid chromatography with diode array detection.

Authors:  Andrew P Neilson; Rodney J Green; Karl V Wood; Mario G Ferruzzi
Journal:  J Chromatogr A       Date:  2006-08-17       Impact factor: 4.759

3.  Endothelial dysfunction in hypercholesterolemia is improved by L-arginine administration: possible role of oxidative stress.

Authors:  Hiroaki Kawano; Takeshi Motoyama; Nobutaka Hirai; Kiyotaka Kugiyama; Hirofumi Yasue; Hisao Ogawa
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

4.  Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide.

Authors:  S N Doshi; K K Naka; N Payne; C J Jones; M Ashton; M J Lewis; J Goodfellow
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

5.  Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study.

Authors:  Shinichi Kuriyama; Taichi Shimazu; Kaori Ohmori; Nobutaka Kikuchi; Naoki Nakaya; Yoshikazu Nishino; Yoshitaka Tsubono; Ichiro Tsuji
Journal:  JAMA       Date:  2006-09-13       Impact factor: 56.272

6.  Effects of acute administration of caffeine on vascular function.

Authors:  Takashi Umemura; Keiko Ueda; Kenji Nishioka; Takayuki Hidaka; Hiroaki Takemoto; Shuji Nakamura; Daisuke Jitsuiki; Junko Soga; Chikara Goto; Kazuaki Chayama; Masao Yoshizumi; Yukihito Higashi
Journal:  Am J Cardiol       Date:  2006-10-16       Impact factor: 2.778

Review 7.  Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect.

Authors:  Sung I Koo; Sang K Noh
Journal:  J Nutr Biochem       Date:  2007-03       Impact factor: 6.048

8.  Degradation of green tea catechins in tea drinks.

Authors:  Z Chen; Q Y Zhu; D Tsang; Y Huang
Journal:  J Agric Food Chem       Date:  2001-01       Impact factor: 5.279

9.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

Review 10.  Mechanisms and effects of green tea on cardiovascular health.

Authors:  Arpita Basu; Edralin A Lucas
Journal:  Nutr Rev       Date:  2007-08       Impact factor: 7.110

View more
  3 in total

1.  Lemon juice, but not tea, reduces the glycemic response to bread in healthy volunteers: a randomized crossover trial.

Authors:  Daniela Freitas; François Boué; Mourad Benallaoua; Gheorghe Airinei; Robert Benamouzig; Steven Le Feunteun
Journal:  Eur J Nutr       Date:  2020-03-23       Impact factor: 5.614

Review 2.  Aging-Induced Impairment of Vascular Function: Mitochondrial Redox Contributions and Physiological/Clinical Implications.

Authors:  Evan Paul Tracy; William Hughes; Jason E Beare; Gabrielle Rowe; Andreas Beyer; Amanda Jo LeBlanc
Journal:  Antioxid Redox Signal       Date:  2021-09-17       Impact factor: 7.468

3.  Intestinal-level anti-inflammatory bioactivities of catechin-rich green tea: Rationale, design, and methods of a double-blind, randomized, placebo-controlled crossover trial in metabolic syndrome and healthy adults.

Authors:  Joanna K Hodges; Jiangjiang Zhu; Zhongtang Yu; Yael Vodovotz; Guy Brock; Geoffrey Y Sasaki; Priyankar Dey; Richard S Bruno
Journal:  Contemp Clin Trials Commun       Date:  2019-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.